This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Asahi Kasei Pharma Corporation, Vernalis (R&D) Ltd. Active years: 2026.
Company Filing History:
2 out of 84 
2 out of 4 Years Active: 2026
Title: Andrew John Potter: Innovator in Medicinal Chemistry
Introduction
Andrew John Potter is an inventor based in Cambridge, GB. He has made significant contributions to the field of medicinal chemistry, particularly through his work with various pharmaceutical companies. Although he currently holds no granted patents, his research and development efforts have the potential to impact therapeutic treatments.
Latest Patent Applications
One of Andrew's notable patent applications is for a compound titled "Pyrimidine- and Nitrogen-containing Bicyclic Compound." This compound is represented by the general formula (1) or a salt thereof, which exhibits superior IRAK-4 inhibitory activity. It is useful as an active ingredient in medicaments for the prophylactic and therapeutic treatment of diseases related to IRAK-4 inhibition.
Conclusion
Andrew John Potter's work in medicinal chemistry showcases his dedication to advancing healthcare solutions. His innovative research continues to pave the way for future developments in the pharmaceutical industry.